University of Geneva researchers identified two key proteins involved in the chromatin remodeling process that regulates gene accessibility, which is crucial for controlled gene expression. Improper regulation of chromatin can activate normally silent DNA segments, leading to malignant transformations in skin cells and neurodevelopmental disorders like autism. Their discoveries illuminate new molecular targets that could enable development of more precise and less toxic cancer therapies, advancing personalized treatment strategies through modulation of epigenetic mechanisms.